The Relative Cost Effectiveness of Insulin Glargine Versus NPH Insulin Using UK Real Life Data in Type 1 Diabetes Mellitus and the Combined Effect of HBA1C and Hypoglycaemia Reduction

Nov-07

Endocrinology Healthcare Cost Pharmacoepidemiology

AUTHORS : Prof Phil McEwan (Details for study: Cardiff University), HEOR, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB – Email: enquiries@heor.co.uk – Profile: https://heor.co.uk/about-us/meet-the-team/phil-mcewan/

JOURNAL : Value in Health

REFERENCE: 10(6):A262-A263

DOI : 10.1016/S1098-3015(10)64977-7

The Relative Cost Effectiveness of Insulin Glargine Versus NPH Insulin Using UK Real Life Data in Type 1 Diabetes Mellitus and the Combined Effect of HBA1C and Hypoglycaemia Reduction

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Increased risk of fracture among patients with iron overload: a population-based matched cohort study